Trillium Asset Management, LLC Novo Nordisk A S Transaction History

Trillium Asset Management, LLC

$4 Billion
Q3 2024

A detailed history of Trillium Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Trillium Asset Management, LLC holds 236,397 shares of NVO stock, worth $20.1 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

236,397

Previous 237,279 0.37%

Holding current value

$20.1 Million

Previous $33.9 Million 16.89%

% of portfolio

0.7%

Previous 0.86%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $105,019 - $128,260	-882 Reduced 0.37%	236,397 $28.1 Million
Q2 2024 Aug 07, 2024	SELL	$122.71 - $146.91 $408,010 - $488,475	-3,325 Reduced 1.38%	237,279 $33.9 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $330,734 - $440,244	-3,239 Reduced 1.33%	240,604 $30.9 Million
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $476,030 - $571,855	-5,423 Reduced 2.18%	243,843 $25.2 Million
Q3 2023 Nov 07, 2023	BUY	$90.94 - $199.54 $9 Million - $19.8 Million	98,999 Added 65.88%	249,266 $22.7 Million
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $4.06 Million - $4.49 Million	-26,016 Reduced 14.76%	150,267 $24.3 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $220,875 - $265,604	-1,669 Reduced 0.94%	176,283 $28.1 Million
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $115,984 - $153,058	-1,131 Reduced 0.63%	177,952 $24.1 Million
Q3 2022 Nov 09, 2022	SELL	$95.28 - $116.93 $62,217 - $76,355	-653 Reduced 0.36%	179,083 $17.8 Million
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $1.87 Million - $2.21 Million	18,144 Added 11.23%	179,736 $20.1 Million
Q1 2022 May 04, 2022	BUY	$93.1 - $112.54 $6.36 Million - $7.68 Million	68,270 Added 73.16%	161,592 $17.9 Million
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $488,508 - $596,522	5,095 Added 5.77%	93,322 $10.5 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $6.76 Million - $8.54 Million	80,132 Added 989.89%	88,227 $8.47 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $22,936 - $26,494	-359 Reduced 4.25%	8,095 $565,000
Q2 2020 Aug 06, 2020	SELL	$58.54 - $67.94 $113,274 - $131,463	-1,935 Reduced 18.63%	8,454 $554,000
Q4 2019 Feb 10, 2020	SELL	$49.86 - $58.26 $84,762 - $99,042	-1,700 Reduced 14.06%	10,389 $601,000
Q3 2019 Nov 06, 2019	BUY	$47.54 - $53.43 $107,202 - $120,484	2,255 Added 22.93%	12,089 $625,000
Q1 2019 May 06, 2019	SELL	$46.36 - $52.63 $2,086 - $2,368	-45 Reduced 0.46%	9,834 $514,000
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $60,440 - $68,748	-1,455 Reduced 12.84%	9,879 $455,000
Q2 2018 Aug 01, 2018	SELL	$44.29 - $50.42 $22,233 - $25,310	-502 Reduced 4.24%	11,334 $523,000
Q1 2018 May 09, 2018	BUY	$48.49 - $58.14 $21,190 - $25,407	437 Added 3.83%	11,836 $583,000
Q3 2017 Nov 02, 2017	BUY	$41.15 - $49.22 $469,068 - $561,058	11,399	11,399 $549,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.

Account

Trillium Asset Management, LLC Novo Nordisk A S Transaction History